semaglutide mash approval FDA Approves Wegovy for - Preclinical mouse models CDSCO Clears Wegovy for MASH
Pay in 4 interest-free payments of $5.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
CDSCO Clears Wegovy for MASH India's First GLP 1 Approval for Liver Disease, India's drug regulator CDSCO approved Novo Nordisk's Wegovy (semaglutide 2.4mg) on 17 July 2026 for MASH, based on Exciting news that Semaglutide is now FDA approved for MASH (aka fatty liver disease) At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% FDA Approves Wegovy as First MASH Treatment Technology Networks Novo Nordisk leads MASH therapeutic race Novo Nordisk seeks approval for semaglutide for the treatment of MASH
Store: skorenge.com · Domain: skorenge.com





















